ArticlePloS one2025
Public-private partnerships for seed industry development in developing countries: Lessons from MasAgro maize in Mexico.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Public-private partnerships (PPPs) are globally recognized for their potential to accelerate genetic improvement and delivery of new high-yielding seed varieties in developing countries. However, despite the strong advocacy for PPPs in crop improvement, there is little empirical evidence about their performance, capacities, and contribution to the development of seed industries and the promotion of competitive seed markets. This paper uses the experience of the MasAgro maize consortium, a PPP in Mexico, to examine crop variety innovation and delivery through PPPs, assess PPPs' capacities to commercialize public germplasm-based varieties, and derive lessons for the design and implementation of future PPPs. Drawing on a combination of multiple data sources, we examined the PPP's performance in the generation, dissemination, and commercialization of new maize hybrids. Our examination over the period 2011-2019 shows that the consortium was successful in maintaining a substantial flow of agronomically competitive maize hybrids, which compared favourably with the number of new varieties generated by national and international seed companies and the public sector. The partnership also contributed to refreshing and rejuvenating the variety portfolios of the consortium companies, which appear to have succeeded in bringing MasAgro varieties quickly into the market. However, seed sales achieved by MasAgro hybrids over this period remained small and multinational companies consistently maintained their leadership in the maize seed market. Our analysis shows that PPPs have strong capacities for the development of competitive seed varieties, but they face significant challenges in scaling up the uptake and adoption of these innovations in highly concentrated markets. To succeed in their objective of delivering affordable, high-quality seed on a large scale to smallholder farmers in developing countries, PPPs need to urgently incorporate a commercial and market-oriented perspective along all steps of the plant breeding and dissemination process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.